Microvision (MVIS) Misses Q2 EPS by 161c

Microvision (NASDAQ: MVIS) reported Q2 EPS of ($1.66), $1.61 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $1 million versus the consensus estimate of $1 million.

For earnings history and earnings-related data on Microvision (MVIS) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance